Young CW - Search Results

1

Biochemical, pharmacological, and phase I clinical evaluation of pseudoisocytidine.

Woodcock TM, Chou TC, Tan CT, Sternberg SS, Philips FS, Young CW, Burchenal JH. Woodcock TM, et al. Among authors: young cw. Cancer Res. 1980 Nov;40(11):4243-9. Cancer Res. 1980. PMID: 7471064 Clinical Trial.

2

Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II).

Kelsen DP, Scher H, Alcock N, Leyland-Jones B, Donner A, Williams L, Greene G, Burchenal JH, Tan C, Philips FS, Young CW. Kelsen DP, et al. Among authors: young cw. Cancer Res. 1982 Nov;42(11):4831-5. Cancer Res. 1982. PMID: 7127319

3

Phase I evaluation of succinylated Acinetobacter glutaminase-asparaginase in adults.

Warrell RP Jr, Chou TC, Gordon C, Tan C, Roberts J, Sternberg SS, Philips FS, Young CW. Warrell RP Jr, et al. Among authors: young cw. Cancer Res. 1980 Dec;40(12):4546-51. Cancer Res. 1980. PMID: 7438089

4

Phase I evaluation of piperazinedione in patients with advanced cancer.

Currie V, Woodcock T, Tan C, Krakoff I, Young C. Currie V, et al. Cancer Treat Rep. 1979 Jan;63(1):73-6. Cancer Treat Rep. 1979. PMID: 369694 Clinical Trial.

5

Phase I evaluation of tetrahydrouridine combined with cytosine arabinoside.

Wong PP, Currie VE, Mackey RW, Krakoff IH, Tan CT, Burchenal JH, Young CW. Wong PP, et al. Among authors: young cw. Cancer Treat Rep. 1979 Aug;63(8):1245-9. Cancer Treat Rep. 1979. PMID: 383291 Clinical Trial.

6

Phase I evaluation of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in immunosuppressed patients with herpesvirus infection.

Young CW, Schneider R, Leyland-Jones B, Armstrong D, Tan CT, Lopez C, Watanabe KA, Fox JJ, Philips FS. Young CW, et al. Cancer Res. 1983 Oct;43(10):5006-9. Cancer Res. 1983. PMID: 6309380

7

Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.

Blumenreich MS, Chou TC, Andreeff M, Vale K, Clarkson BD, Young CW. Blumenreich MS, et al. Among authors: young cw. Cancer Res. 1984 Feb;44(2):825-30. Cancer Res. 1984. PMID: 6692380

8

Effect of very high-dose thymidine infusions on leukemia and lymphoma patients.

Blumenreich MS, Woodcock TM, Andreeff M, Hiddemann W, Chou TC, Vale K, O'Hehir M, Clarkson BD, Young CW. Blumenreich MS, et al. Among authors: young cw. Cancer Res. 1984 May;44(5):2203-7. Cancer Res. 1984. PMID: 6713407

9

Phase I and pharmacological studies of pentamethylmelamine administered by 24-hour intravenous infusion.

Casper ES, Gralla RJ, Lynch GR, Jones BR, Woodcock TM, Gordon C, Kelsen DP, Young CW. Casper ES, et al. Among authors: young cw. Cancer Res. 1981 Apr;41(4):1402-6. Cancer Res. 1981. PMID: 6783296

10

Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule.

Woodcock TM, Schneider RJ, Young CW. Woodcock TM, et al. Among authors: young cw. Cancer Treat Rep. 1980 Jan;64(1):53-5. Cancer Treat Rep. 1980. PMID: 6892893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters